, India
4 views

India’s vaccine export delays spell doom for low-income nations

The country’s SII makes up about half of Covax supply.

The Serum Institute India said that it is unlikely to restart deliveries to Covax until the end of 2021, which could cause a further lag in vaccine coverage amongst countries reliant on Covax, which are generally lower-income countries, according to a report from Fitch Solutions.

Gavi, a founding organisation of Covax, expects that 190 million doses of vaccine expected to be delivered by the end of June 2021 will now remain in India. It also said that it is hopeful deliveries will resume in Q3 but at a reduced level. This can leave countries vulnerable to recurring Covid-19 outbreaks, Fitch said.

Currently SII makes up about half of Covax supply, therefore a several-month delay would seriously slow the progress of Covax, as well as for the vaccination campaigns of countries reliant on Covax.

“We expect that the worst affected will be those in the Covax Advanced Market Commitment (AMC) scheme given lower incomes to reach purchase deals directly with manufacturers,” the report stated.

However, a bleaker outlook could be averted if another manufacturer is able to step in and reach a deal with Covax to replace the shortfall from SII. However, this outcome is unlikely given most manufacturers have already committed direct deals with countries that are likely to take precedence over any deals with Covax.

“Another possibility is that countries with high vaccination coverage begin to donate significant volumes of vaccines either directly or through Covax. US President Joe Biden announced on May 17 2021 that the US will donate some 80mn doses by the end of June 2021, however, this remains well below the 190mn dose Covax shortfall,” the report added.

Significant donations from the US and other countries nearing vaccination coverage will be required throughout 2021 to avoid severe delays for Covax reliant countries, the report added.
 

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.